Agenus (AGEN) Receivables - Net (2010 - 2026)
Agenus' (AGEN) quarterly Receivables - Net came in at $6.6 million in Q1 2026, up 1753.67% year-on-year from $354000.0 in Q1 2025, and up 258.38% quarter-over-quarter from $1.8 million in Q4 2025.
Agenus (AGEN) Receivables - Net (2010 - 2026) Analysis & Trends
Agenus' Receivables - Net history runs 17 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- On a quarterly basis, Receivables - Net rose 1753.67% year-over-year to $6.6 million in Q1 2026; TTM through Mar 2026 was $6.6 million, a 1753.67% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 349.88% from the prior year.
- Receivables - Net grew to $6.6 million in Q1 2026 per AGEN's latest filing, from $1.8 million in the prior quarter.
- Across five years, Receivables - Net topped out at $25.8 million in Q4 2023 and bottomed at $207000.0 in Q3 2024.
- The 5-year median for Receivables - Net is $1.3 million (2022), against an average of $4.3 million.
- Across the five-year window, Receivables - Net tumbled 98.42% in 2024 and jumped 1753.67% in 2026, its largest moves.
- Year by year, Receivables - Net stood at $2.7 million in 2022, then jumped by 842.58% to $25.8 million in 2023, then tumbled by 98.42% to $407000.0 in 2024, then soared by 349.88% to $1.8 million in 2025, then jumped by 258.38% to $6.6 million in 2026.
- Per Business Quant, the three latest AGEN Receivables - Net figures stand at $6.6 million (Q1 2026), $1.8 million (Q4 2025), and $538000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.56 Mn |
| Mar 31, 2026 | 6.56 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 538,000.00 |
| Sep 30, 2025 | 538,000.00 |
| Jun 30, 2025 | 709,000.00 |
| Jun 30, 2025 | 709,000.00 |
| Mar 31, 2025 | 354,000.00 |
| Mar 31, 2025 | 354,000.00 |
| Dec 31, 2024 | 407,000.00 |
| Dec 31, 2024 | 407,000.00 |
| Sep 30, 2024 | 207,000.00 |
| Sep 30, 2024 | 207,000.00 |
| Jun 30, 2024 | 719,000.00 |
| Jun 30, 2024 | 719,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 25.84 Mn |
| Dec 31, 2023 | 25.84 Mn |